Image of Maha Reda Farhat

Maha Reda Farhat, M.D., M.D.,C.M.

617-432-4598

Maha Farhat  holds an MD from the McGill University Faculty of Medicine and a MSc in biostatistics from the Harvard Chan School of Public Health. She is also a practicing physician at the Massachusetts General Hospital Division of Pulmonary and Critical Care Medicine.

Program in Global Surgery and Social Change

Dr. Farhat's research focuses on the development and application of methods for associating genotype and phenotype in infectious disease pathogens, with a strong emphasis on translation to better diagnostics and surveillance in resource-poor settings. To date, Farhat's work has focused on the pathogen Mycobacterium tuberculosis and spans the spectrum from computational analysis to field studies. She is PI and Co-Investigator on several large projects funded by NIH including the NIAID and the BD2K initiative.


DBMI Research Areas
DBMI Courses
COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation.
Authors: Authors: Patton MJ, Orihuela CJ, Harrod KS, Bhuiyan MAN, Dominic P, Kevil CG, Fort D, Liu VX, Farhat M, Koff JL, Lal CV, Gaggar A, Richter RP, Erdmann N, Might M, Gaggar A.
Crit Care
View full abstract on Pubmed
Rethinking global digital health and AI-for-health innovation challenges.
Authors: Authors: Farlow A, Hoffmann A, Tadesse GA, Mzurikwao D, Beyer R, Akogo D, Weicken E, Matika T, Nweje MI, Wamae W, Arts S, Wiegand T, Bennett C, Farhat MR, Gröschel MI.
PLOS Glob Public Health
View full abstract on Pubmed
Addressing patients' unmet needs related to multidrug-resistant tuberculosis (MDR-TB) care: A qualitative research study from Pune city, India.
Authors: Authors: Atre S, Jagtap J, Faqih M, Dumbare Y, Sawant T, Ambike S, Farhat M.
PLoS One
View full abstract on Pubmed
COVID-19 and global childhood tuberculosis notifications.
Authors: Authors: Atre S, Chatterjee A, Farhat M.
Lancet Glob Health
View full abstract on Pubmed
High Throughput Sequencing for Clinical Tuberculosis: An Overview.
Authors: Authors: Ness TE, DiNardo A, Farhat MR.
Pathogens
View full abstract on Pubmed
A convolutional neural network highlights mutations relevant to antimicrobial resistance in Mycobacterium tuberculosis.
Authors: Authors: Green AG, Yoon CH, Chen ML, Ektefaie Y, Fina M, Freschi L, Gröschel MI, Kohane I, Beam A, Farhat M.
Nat Commun
View full abstract on Pubmed
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A genotypic analysis.
Authors: Authors: Walker TM, Miotto P, Köser CU, Fowler PW, Knaggs J, Iqbal Z, Hunt M, Chindelevitch L, Farhat M, Cirillo DM, Comas I, Posey J, Omar SV, Peto TE, Suresh A, Uplekar S, Laurent S, Colman RE, Nathanson CM, Zignol M, Walker AS, Crook DW, Ismail N, Rodwell TC.
Lancet Microbe
View full abstract on Pubmed
Tuberculosis Pathways to Care and Transmission of Multidrug Resistance in India.
Authors: Authors: Atre SR, Jagtap JD, Faqih MI, Dumbare YK, Sawant TU, Ambike SL, Bhawalkar JS, Bharaswadkar SK, Jogewar PK, Adkekar RS, Hodgar BP, Jadhav V, Mokashi ND, Golub JE, Dixit A, Farhat MR.
Am J Respir Crit Care Med
View full abstract on Pubmed
Benchmarking the empirical accuracy of short-read sequencing across the M. tuberculosis genome.
Authors: Authors: Marin M, Vargas R, Harris M, Jeffrey B, Epperson LE, Durbin D, Strong M, Salfinger M, Iqbal Z, Akhundova I, Vashakidze S, Crudu V, Rosenthal A, Farhat MR.
Bioinformatics
View full abstract on Pubmed
Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India.
Authors: Authors: Mave V, Chen L, Ranganathan UD, Kadam D, Vishwanathan V, Lokhande R, S SK, Kagal A, Pradhan NN, Shivakumar SVBY, S Paradkar M, Deshmukh S, Tornheim JA, Kornfeld H, Farhat M, Gupta A, Padmapriyadarsini C, Gupte N, Golub JE, Mathema B, Kreiswirth BN.
Clin Infect Dis
View full abstract on Pubmed